Granules India has surged 8% to Rs 375, extending its over 10% rally in the past two days on the BSE, after reporting a strong 90% year-on-year (yoy) jump in consolidated net profit at Rs 23.63 crore for the quarter ended March 31, 2014 (Q4FY14). The pharmaceutical company had posted a profit of Rs 12.41 crore in the year-ago quarter.
The company’s net sales during the quarter under review increased by 55% to Rs 317 crore from Rs 204 crore in Q4 last year.
the EBITDA or operating margin has improved by 227 basis points to 16.2% in Q4FY14 compared with the corresponding quarter in previous fiscal.
Granules India said the growth was driven by strong performances across all manufacturing facilities, including the company's Chinese joint venture.
The company also improved utilisation in the newly expanded facility throughout the year and expects to continue improving utilisation in the future. In addition, the API (active pharmaceutical ingredients) facilities continued to increase production which contributed to strong sales, it added.
The stock opened at Rs 349 and hit a new high of Rs 383 on the BSE. A combined 1.93 million shares changed hands on the counter till late noon trades on the BSE and NSE.
The company’s net sales during the quarter under review increased by 55% to Rs 317 crore from Rs 204 crore in Q4 last year.
the EBITDA or operating margin has improved by 227 basis points to 16.2% in Q4FY14 compared with the corresponding quarter in previous fiscal.
Granules India said the growth was driven by strong performances across all manufacturing facilities, including the company's Chinese joint venture.
The company also improved utilisation in the newly expanded facility throughout the year and expects to continue improving utilisation in the future. In addition, the API (active pharmaceutical ingredients) facilities continued to increase production which contributed to strong sales, it added.
The stock opened at Rs 349 and hit a new high of Rs 383 on the BSE. A combined 1.93 million shares changed hands on the counter till late noon trades on the BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%